Skip to Main Content
Menu
Close
About Us
Science & Pipeline
About Mitochondrial Diseases
Join Us
News
Contact Us
News
Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies
September 12, 2022
Press
Releases
Pretzel: modulating the mitochondrial genome
BioCentury
Pretzel Gets $72.5M for Gene Editing & Small Molecules Against Mitochondrial Targets
Timmerman Report
Pretzel Therapeutics launches to advance mitochondria-based therapies
Chemical & Engineering News
Waltham biotech Pretzel Therapeutics launches with $72.5m
Boston Globe
Freshly baked: Pretzel Therapeutics takes out the oven mitts to drug diseases in the powerhouse of the cell
Endpoints News
Mitochondrial drugs, with a twist: Pretzel Therapeutics launches with $72.5M in funding
BioPharma Dive
In the News